MOHAMEDLATIF SAIYAD: Open Payments
NPI 1619233061 · MARIETTA, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,463 in 87 payments from 16 companies in 2025. Trend: 2023 $2,031 · 2024 $1,275 · 2025 $1,463
Food & beverage: $1,455Education: $8
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $224 |
| Vanda Pharmaceuticals Inc. | 8 | $194 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $166 |
| Alkermes, Inc. | 10 | $154 |
| Otsuka America Pharmaceutical, Inc. | 9 | $151 |
| Sage Therapeutics, LLC | 7 | $148 |
| Neurocrine BioSciences, Inc. | 4 | $87 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $75 |
| E.R. Squibb & Sons, L.L.C. | 3 | $65 |
| Lundbeck LLC | 3 | $60 |
Products named: VRAYLAR, REXULTI, FANAPT, TRINTELLIX, ZURZUVAE, INGREZZA, LYBALVI, CAPLYTA.
Industry payments across OH — which companies pay providers there.
